Q1 2020 Holdings
Filed 2020-05-15 | 142 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $370.2M | 3,287,400 | 25.8% |
| Alector Inc(ALEC) | COM | 014442107 | $200.9M | 8,327,691 | 14.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $158.2M | 4,847,300 | 11.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $152.0M | 480,400 | 10.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $139.3M | 4,673,850 | 9.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $79.4M | 1,335,700 | 5.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $58.6M | 1,652,696 | 4.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $45.7M | 540,500 | 3.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $40.1M | 995,000 | 2.8% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $37.2M | 2,399,880 | 2.6% |
| Atricure Inc(ATRC) | COM | 04963C209 | $31.2M | 928,189 | 2.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $30.0M | 2,039,282 | 2.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $25.3M | 1,380,160 | 1.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $19.4M | 1,336,547 | 1.4% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $17.4M | 229,000 | 1.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $14.3M | 6,767,584 | 1.0% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $6.9M | 2,525,654 | 0.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.8M | 28,591 | 0.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $2.0M | 68,100 | 0.1% |
| Tricida Inc(1T7) | COM | 89610F101 | $211.5K | 9,614,280 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $200.0K | 7,406,307 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $199.2K | 2,589,100 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $186.0K | 2,071,385 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $175.5K | 737,400 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $168.5K | 13,822,463 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $166.1K | 5,548,326 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $137.9K | 2,474,800 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $122.6K | 2,745,327 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $110.0K | 1,471,100 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $109.7K | 6,962,899 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $109.4K | 1,423,300 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $101.1K | 4,004,442 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $100.5K | 2,711,013 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $100.0K | 1,155,015 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $99.9K | 3,347,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $98.3K | 3,012,100 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $91.0K | 338,000 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $89.9K | 638,558 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $88.3K | 902,449 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $88.0K | 280,300 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $83.7K | 169,100 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $77.9K | 439,700 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $69.4K | 7,025,832 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $69.4K | 2,341,700 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $63.8K | 709,800 | 0.0% |
| Stryker Corp(SYK) | COM | 863667101 | $61.8K | 371,100 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $54.8K | 3,180,100 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $51.2K | 1,148,723 | 0.0% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $48.1K | 3,582,320 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $47.8K | 1,547,646 | 0.0% |